drug protocol number

MB12-C-02-24

drug sponsor

mAbxience Research SLU / Balsam

drug study

MB12 (proposed pembrolizumab biosimilar)

drug trial site

King Saud University Medical City (Riyadh)

drug status

Ongoing

drug phase